Increasing Accessibility to Personalized Cancer Treatment Options - Every cancer patient is different and deserves treatment of the highest quality that is personalized, affordable, and easily accessible. 85% of US cancer patients receive treatments in community practices where treating oncologists are overwhelmed with the influx of new tests and treatments while trying to manage their busy practices. Massive Bio translates the world-class oncology knowledge of the large cancer centers'​ experts, facilitates a virtual tumor board collaboratively with the treating oncologist, and advises the patient and treating oncologist to operationalize these expert recommendations at the point of care thereby, eliminating additional time, travel, and cost.

Increasing Accessibility to Personalized Cancer Treatment Options - Every cancer patient is different and deserves treatment of the highest quality that is personalized, affordable, and easily accessible. 85% of US cancer patients receive treatments in community practices where treating oncologists are overwhelmed with the influx of new tests and treatments while trying to manage their busy practices. Massive Bio translates the world-class oncology knowledge of the large cancer centers'​ experts, facilitates a virtual tumor board collaboratively with the treating oncologist, and advises the patient and treating oncologist to operationalize these expert recommendations at the point of care thereby, eliminating additional time, travel, and cost.

Eviti is an Evidence Based Clinical Decision Support Platform for Oncology supporting Providers and Payers

NantHealth is a healthcare company providing an evidence-based platform for healthcare diagnostics. It is a transformational healthcare company converging science and technology through an integrated clinical platform that’s empowering physicians, patients, payers, and researchers to transcend the traditional barriers of today’s healthcare system. The company's solutions are advancing diagnostics to better identify and target specific disease characteristics; transforming clinical delivery with clinical data and promoting wellness for a healthier, happier world. They are building an integrated, evidence-based, genomically-informed, personalized approach to the delivery of care and the development of next-generation healthcare solutions.